![Yves Rosconi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Yves Rosconi
Vorsitzender bei Laurent Pharmaceuticals, Inc.
Ursprung des Netzwerks ersten Grades von Yves Rosconi
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 12 | |
Laurent Pharmaceuticals, Inc.
![]() Laurent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Laurent Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm develops clinical stage, orally-active drug candidate with potential to modulate the immuno-inflammatory response in cystic fibrosis patients. The company was founded in 2012 and is headquartered in Montr?al, Canada.
4
| Holding Company | Pharmaceuticals: Major | 4 |
Otsuka Canada Pharmaceutical, Inc.
![]() Otsuka Canada Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Canada Pharmaceutical, Inc. is a Canadian healthcare company that commercializes Otsuka medicines in Canada, with a focus on neuroscience and nephrology. The company is based in Saint-Laurent, Canada and was founded in 1921. The company is dedicated to improving patients' health and the quality of human life. Otsuka Pharmaceutical Co., Ltd., the parent company, is a healthcare company with the corporate philosophy of creating new products for better health worldwide.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Yves Rosconi
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
University of Montréal | College/University | Undergraduate Degree Corporate Officer/Principal Graduate Degree Doctorate Degree Doctorate Degree | |
Mimetogen Pharmaceuticals, Inc.
![]() Mimetogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Mimetogen Pharmaceuticals, Inc. develops peptidomimetic small molecule drugs against glaucoma and cancer. Its product mimic the effects of neurotrophin proteins that help to maintain the health and growth of cells and tissues found in the eye. Mimetogen provides tyrosine kinase agonists that prevent neuronal death; small molecule tyrosine kinase receptor agonists, which stimulates mucin secretion from conunctival goblet cells; and small molecule neurotrophin mimetics that rescues retinal pigment epithelial cells from oxidative stress-induced apoptosis. The company was founded by Garth Cumberlidge and H. Uri Saragovi in 2005 and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
University of Toronto | College/University | Graduate Degree Doctorate Degree | |
Millendo Therapeutics SAS
![]() Millendo Therapeutics SAS Medical SpecialtiesHealth Technology Millendo Therapeutics SAS provides pharmaceutical research services. It engages in the development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases and rare diseases. The company was founded by Thierry Abribat, André de Villers, Ezio Ghigo and Aart Jan van der Lely on April 23, 2007 and is headquartered in Ecully, France. | Medical Specialties | Founder Chief Tech/Sci/R&D Officer | |
Sciences Po | College/University | Undergraduate Degree | |
Université de Bordeaux | College/University | Undergraduate Degree | |
Cisbio Bioassays SAS
![]() Cisbio Bioassays SAS Medical SpecialtiesHealth Technology Cisbio Bioassays SAS develops immunoassays and other related pharmaceutical products. The firm specializes in anti-bodies, vitro diagnostics, and medication for various diseases such as cancer and neurodegenerative disorder. The company was founded in 1986 and is headquartered in Codolet, France. | Medical Specialties | President | |
Rhone-Poulenc Rorer SA | Corporate Officer/Principal | ||
Aventis, Inc. | Corporate Officer/Principal | ||
ION BEAM APPLICATIONS, SA | Medical Specialties | Corporate Officer/Principal | |
Ecole Nationale d'Administration | College/University | Undergraduate Degree | |
California State University-Sacramento | College/University | Graduate Degree | |
CIS Bio International SA
![]() CIS Bio International SA Pharmaceuticals: MajorHealth Technology CIS Bio International SA engages in the distribution of radiopharmaceuticals for diagnosis and therapy. The company is headquartered in Saclay, France. | Pharmaceuticals: Major | Chairman | |
University College London | College/University | Graduate Degree | |
Montréal Exchange, Inc.
![]() Montréal Exchange, Inc. Investment Banks/BrokersFinance Montréal Exchange, Inc. engages in the operation and development of market and clearing services for Canadian and international clients and to commercialize internally developed technology solutions. The Group operates in two segments, namely, Exchange and Clearing House. The Exchange segment acts as the only standardized financial derivatives exchange in Canada, providing a complete range of equity, index and interest rate derivatives. The Clearing House segment acts as clearing house and guarantor for derivative instruments traded at the MX and certain other derivative instruments from the over-the-counter market. The company is headquartered in Montreal, Canada. | Investment Banks/Brokers | Chief Executive Officer | |
Autorité des marchés financiers | General Government | Chairman | |
North American Free Trade Agreement Secretariat | Supranational | Corporate Officer/Principal | |
Conseil du medicament du Québec | Chairman | ||
Clinipharm, Inc. | Corporate Officer/Principal | ||
Régie de l'assurance maladie du Québec | General Government | Director/Board Member | |
Health Canada | General Government | Director/Board Member | |
Ernst & Young LLP (Canada)
![]() Ernst & Young LLP (Canada) Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP (Canada) engages in the provision of consulting, assurance, tax, and transaction services. The company is headquartered in Toronto, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
ALEXZA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Otsuka America Pharmaceutical, Inc.
![]() Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America Pharmaceutical, Inc. manufactures and supplies pharmaceutical products. It develops drugs for neuroscience, cardiovascular, and gastrointestinal treatments. The company was founded in 1989 and is headquartered in Rockville, MD. | Pharmaceuticals: Major | Chief Executive Officer | |
TAISHO PHARMACEUTICAL INDONESIA TBK PT | Pharmaceuticals: Major | Chairman | |
INSEAD | College/University | Masters Business Admin | |
Inhibitex LLC
![]() Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | Pharmaceuticals: Major | Director/Board Member | |
Otsuka Pharmaceutical Co., Ltd.
![]() Otsuka Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Otsuka Pharmaceutical Co. Ltd. engages in the manufacturing, distributing, exporting, and importing of pharmaceuticals, clinical testing equipment, medical device and equipment, food products, cosmetics, and other related products. Its operations are carried out through the following business divisions: Pharmaceutical Business and Nutraceutical Business. The Pharmaceutical Business division engages in the manufacture and sale of pharmaceutical products for the diagnosis and treatment of diseases. The Nutraceutical Business division provides nutritional products, cosmetics and medicines that support day-to-day health maintenance and improvement. The company was founded on August 10, 1964 and is headquartered in Tokyo, Japan. | Pharmaceuticals: Major | Director/Board Member | |
AdhereTech LLC
![]() AdhereTech LLC Electronic Equipment/InstrumentsElectronic Technology AdhereTech LLC provides prescription drug packaging solutions. The firm develops smart pill bottle that enables to know when pills and liquid medication is missed by patients. The company was founded by Josh Stein and is headquartered in New York, NY. | Electronic Equipment/Instruments | Chief Executive Officer | |
Reset Pharmaceuticals, Inc.
![]() Reset Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reset Pharmaceuticals, Inc. is a clinical-stage biotechnology company that focuses on developing and commercializing novel treatments for patients suffering from mental illness related to life-altering diseases. Reset Pharmaceuticals is based in Great Neck, NY and was founded by Philip Taub and Jan-Anders Karlsson. The company's lead product candidate, the oral psilocybin, is being developed to treat demoralization syndrome in patients with cancer. Reset Pharma has a highly experienced team with a strong track record of successful development, approvals, and launches of neuroscience drugs. The company also has a scientific advisory board of key opinion leaders in psychiatry, oncology, and psychedelics, as well as a strategic advisory board of business leaders and financial experts. | Pharmaceuticals: Major | Chief Executive Officer | |
The University of Algiers | College/University | Doctorate Degree | |
Université d'Aix-Marseille | College/University | Undergraduate Degree | |
BioTalent Canada
![]() BioTalent Canada Miscellaneous Commercial ServicesCommercial Services BioTalent Canada is a non-profit organization, which focuses on building partnerships and skills for Canada?s bio-economy to ensure the industry has access to job-ready people. It connects employers with job seekers, delivers human resource information, and skills development tools so the biotech industry through projects, research and product development .The company is headquartered in Ottawa, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
Canadian Investor Relations Institute
![]() Canadian Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services The Canadian Investor Relations Institute (CIRI) is a professional organization that aims to enhance the credibility and competency of the investor relations profession. CIRI has four chapters located in different regions. The organization also provides insights on ESG processes and reporting for issuers at various stages in their ESG journey. The non-profit company is based in Oakville, ON, Canada. CIRI provides resources, professional development, networking opportunities, and advocacy to support the IR community. The organization has over 500 members, with most responsible for IR at publicly-traded companies. Visible Alpha is a sponsor of CIRI that enhances the investment research process. CIRI publishes IR Directions, a magazine that explores current and emerging practices of board reporting and engagement. Nathalie Megann has been the CEO of the Canadian company since 2004. | Miscellaneous Commercial Services | Director/Board Member | |
University of Manitoba | College/University | Masters Business Admin | |
Fasken Martineau DuMoulin LLP
![]() Fasken Martineau DuMoulin LLP Miscellaneous Commercial ServicesCommercial Services Fasken Martineau DuMoulin LLP operates as law firm. It provides legal services to construction, financial, insurance, life sciences, corporate, and commercial industry. It offers Labour employment and human rights, litigation and dispute resolution, and privacy and cybersecurity risk management. The company was founded in 1863 and is headquartered in Toronto, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Québec Bar Assoication
![]() Québec Bar Assoication Financial ConglomeratesFinance The Québec Bar Association is a professional organization that oversees the practice of over 29,000 lawyers in all areas of law. The organization is based in Montréal, Canada. and has subsidiaries in Canada. The mission of the association is to ensure the protection of the public, contribute to accessible and quality justice, and defend the rule of law. | Financial Conglomerates | Corporate Officer/Principal | |
King's College, Cambridge | College/University | Graduate Degree | |
Université Laval | College/University | Graduate Degree | |
Pfizer Global Pharmaceuticals, Inc.
![]() Pfizer Global Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Pfizer Global Pharmaceuticals, Inc. manufactures, and markets prescription medicines. It markets medicines for diseases which include infections, arthritis, depression, hypertension and other heart disorders, as well as certain types of cancer. Pfizer Global Pharmaceuticals is located in New York, NY. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
iNovia Capital, Inc.
![]() iNovia Capital, Inc. Investment ManagersFinance iNovia Capital, Inc., formerly MSBi Capital, is a venture capital firm founded in 2001 by Shawn Abbott. The firm is headquarters in Montreal Canada. | Investment Managers | Private Equity Analyst |
Statistik
International
Kanada | 19 |
Vereinigte Staaten | 15 |
Frankreich | 11 |
Vereinigtes Königreich | 3 |
Niederlande | 2 |
Sektoral
Health Technology | 21 |
Consumer Services | 14 |
Government | 5 |
Commercial Services | 5 |
Finance | 4 |
Operativ
Director/Board Member | 45 |
Corporate Officer/Principal | 26 |
President | 24 |
Chief Executive Officer | 17 |
Chairman | 12 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Yves Rosconi
- Unternehmensverbindungen